Tenderwize
Back to tender search

Supply of positron-emitting radiopharmaceuticals for nuclear medicine

Centre Hospitalier Angoulème·ANGOULEME CEDEX 9, France·EUR 2.6M·Deadline Jul 20, 2026 · 26 days left·Open·Supplies·Framework
Sign up to saveOpen documentsTED notice
High valueStructured notice only
Original notice title

Fourniture de médicaments émetteurs de positons destinés au service de Médecine Nucléaire

55/100

Opportunity Score

Needs reviewMedium complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

55 / 100

Complexity

65 / 100

Risk factors

Full procurement documents were not analyzed; key requirements (e.g., technical specifications, financial guarantees) m...

All submissions must be in French; non-French speakers will need translation resources.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • EUR 2.6M estimated value
  • Framework procurement
  • Supplies contract
  • 3 lots
  • Duration 24 MONTH
  • Supply of positron-emitting radiopharmaceuticals (PET tracers) for nuclear medicine
  • Products: Fludeoxyglucose (18F), Flurocholine (18F), Fluorodopa (18F), Piflufolastat (18F) injectable solutions
Show full summary

This is a framework agreement for the supply of positron-emitting radiopharmaceuticals to the Nuclear Medicine department of Centre Hospitalier Angoulème in France. It is divided into multiple lots, each for a specific radiopharmaceutical product. The tender is an open procedure with a total estimated value of €2,620,000. Bids must be submitted electronically by 20 July 2026 at 10:00 UTC. The procurement documents are available online, but only the TED notice was analyzed—full procurement documents were not extracted.

Risks

Full procurement documents were not analyzed; key requirements (e.g., technical specifications, financial guarantees) m...

All submissions must be in French; non-French speakers will need translation resources.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Open procedure
  • Framework agreement (multiple operators, maximum 1 operator per lot?)

Administrative

Requirements may be incomplete.

Award Criteria

Lot 1

Valeur technique : Pour chacun des lots, l'offre du candidat est jugée en fonction des réponses apportées dans l'annexe au CCP - Cadre de réponse Technique dudit lot concerné

Lot 2

Le candidat proposant l'offre (montant total HT de la prestation indiquée dans le Bordereau de Prix Unitaire) la plus faible se verra attribuer la note maximale; les notes des autres candidats seront calculées à partir de cette meilleure offre (référence) de la manière suivante : N = (offre la plus basse / offre notée) / x 40 points N : correspond à la Note attribuée à l'offre du candidat. Offre la plus basse : est égal au Montant Total HT de l'offre la moins disante. Offre notée : est égal au Montant Total HT de l'offre du candidat

Lot 3

L'offre des candidats est jugée en fonction des réponses apportées dans l'annexe 5 au CCP Questionnaire performance environnementale

Lot 4

Valeur technique : Pour chacun des lots, l'offre du candidat est jugée en fonction des réponses apportées dans l'annexe au CCP - Cadre de réponse Technique dudit lot concerné

Buyer

Name

Centre Hospitalier Angoulème

Location

ANGOULEME CEDEX 9, FRA

Buyer profile

Open profile

Identifier

26160034000010

Lots (4)

LOT-0001

Solution injectable de FLUDESOXYGLUCOSE (18F) en flacon multidose

Supply of Fludeoxyglucose (18F) injectable solution in multidose vials.

SuppliesFrameworkEU fundedElectronic submission

EUR 1.6M

Estimated value

Location

ANGOULEME, France

Duration

24 MONTH

Category

Pharmaceutical products

Selection criteria

Quality

Deadline

Deadline Jul 20, 2026

LOT-0002

Solution injectable prête à l'emploi de FLUROCHOLINE (18F) en flacon multidose

Supply of Flurocholine (18F) injectable solution ready-to-use in multidose vials.

SuppliesFrameworkEU fundedElectronic submission

EUR 100k

Estimated value

Location

ANGOULEME, France

Duration

24 MONTH

Category

Pharmaceutical products

Selection criteria

Price

Deadline

Deadline Jul 20, 2026

LOT-0003

Solution injectable prête à l'emploi de FLUORODOPA (18F) en MBQ en flacon multidose

Supply of Fluorodopa (18F) injectable solution ready-to-use in MBq multidose vials.

SuppliesFrameworkEU fundedElectronic submission

EUR 800k

Estimated value

Location

ANGOULEME, France

Duration

24 MONTH

Category

Pharmaceutical products

Selection criteria

Quality

Deadline

Deadline Jul 20, 2026

LOT-0004

Solution injectable prête à l'emploi de PIFLUFOLASTAT (18F) en flacon multidose

Solution injectable prête à l'emploi de PIFLUFOLASTAT (18F) en flacon multidose

SuppliesFrameworkEU fundedElectronic submission

Location

ANGOULEME, France

Duration

24 MONTH

Category

Pharmaceutical products

Selection criteria

Quality

Procurement Details

Publication date
15 Jun 2026
Notice type
Contract notice — standard
Languages
French

Reference metadata

Notice subtype
16
Notice version
1
Legal basis
32014L0024

Reference IDs

Tender ID
413289-2026

Documents (2)

Procurement document 1Submission portal 1

Similar tenders

Denmark – Pharmaceutical products – Amgros 2027 1.1051.b

DNKAug 20

Poland – Pharmaceutical products – Dostawa produktów leczniczych do SPZZOZ w Wyszkowie

POLJul 27

Romania – Pharmaceutical products – MEDICAMENTE - PRODUSE FARMACEUTICE

ROUJul 21

Denmark – Pharmaceutical products – Amgros 2027 1.1052.b

DNKAug 20

Latvia – Pharmaceutical products – Par reģistrēto un nereģistrēto medikamentu piegādi Elektronisko iepirkumu sistēmas dalībniekiem

LVAJul 20

Spain – Pharmaceutical products – Suministro de Aflibercept (DOE) Intravítreo 40 mg/ml

ESPJul 21